Back to Agenda
Session 1 Plenary: Advancing Regulatory Innovation: Canada’s Role in Global Collaboration
Session Chair(s)
Tharany Ganesh, MSC
Head, Regulatory Affairs, AstraZeneca Canada Inc., Canada
Katalin Bertenyi, MSC
Manager, Centre for Blood, Blood Products and Biotherapeutics, Health Canada, Canada
This session will provide an in-depth exploration of Health Canada’s current and future priorities including key regulatory initiatives. Attendees will gain insights into Health Canada engagement with international partners to advance regulatory collaboration on a global scale. The discussion will include diverse perspectives from industry representatives and patient groups, highlighting the collective impact of collaborative efforts on public health outcomes and regulatory innovation.
- Advancing Regulatory Innovation: Canada’s Role in Global Collaboration
Kelly Robinson, Health Canada - Enabling Faster Access and the Launch of Innovative Medicines and Vaccines
Jenny Buckley, Innovative Medicines Canada - Enhancing Patient Access to Therapies
Jessy Ranger, Myeloma Canada - What do the Metrics Tell Us
Neil McAuslane, Centre for Innovation in Regulatory Science (CIRS)
Learning Objective : At the conclusion of this session, participants should be able to:- Describe Health Canada’s current and future regulatory priorities and international collaboration pathways
- Understand key regulatory metrics stemming from international collaboration pathways and opportunities
- Gain insights on industry and patient group perspectives on collaboration pathways and future considerations
Speaker(s)
Kelly Robinson, MSC
Director General, Pharmaceutical Drugs Directorate, Health Canada, Canada
Advancing Regulatory Innovation: Canada’s Role in Global Collaboration
Jenny Buckley, MA, MSC
Director, Policy, Innovative Medicines Canada, Canada
Enabling Faster Access and the Launch of Innovative Medicines and Vaccines
Neil McAuslane, PHD, MSC
Scientific Director, Centre for Innovation in Regulatory Science (CIRS), United Kingdom
What do the Metrics Tell Us
Jessy Ranger
Director, Patient Programs, Health Policy & Advocacy, Myeloma Canada, Canada
Enhancing Patient Access to Therapies
Have an account?